The antibody Herceptin, which is used to treat breast cancers that overexpress the HER2/neu protein, has been tried with some success in a phase II trial in women with uterine papillary serous carcinomas that overexpress HER2/neu.
cancer | American Cancer Society | breast cancer | National Cancer Institute | Cancer Research UK | Cancer | Memorial Sloan-Kettering Cancer Center | Fred Hutchinson Cancer Research Center | colorectal cancer | Tropic of Cancer | prostate cancer | Macmillan Cancer Support | Ludwig Institute for Cancer Research | liver cancer | Fox Chase Cancer Center | Colorectal cancer | Teenage Cancer Trust | Princess Margaret Cancer Centre | International Agency for Research on Cancer | Esophageal cancer | Breast Cancer Care | Breast Cancer | Union for International Cancer Control | Tropic of Cancer (novel) | Nevada Cancer Institute | Marie Curie Cancer Care | Juravinski Cancer Centre | Institute for Cancer Research | Eppley Institute for Research in Cancer and Allied Diseases | Clinical Cancer Research |